Chris Labaki(@Chrislabaki1) 's Twitter Profileg
Chris Labaki

@Chrislabaki1

PGY-1 @BIDMC_IM | Research Associate @DanaFarber | via @DanaFarber @USJLiban | Interested in Oncology

ID:976888208100339718

calendar_today22-03-2018 18:27:53

1,5K Tweets

835 Followers

934 Following

Follow People
Ryan Collins(@RyanLCollins13) 's Twitter Profile Photo

🚨🔊Interested in structural variants? Genome sequencing? Pediatric cancers? Germline variants+cancer risk? Rare variants+rare diseases?

If so (or even if not!), I'm delighted to share the first paper from my postdoc Eli Van Allen Dana-Farber:

biorxiv.org/content/10.110…

1/12

🚨🔊Interested in structural variants? Genome sequencing? Pediatric cancers? Germline variants+cancer risk? Rare variants+rare diseases? If so (or even if not!), I'm delighted to share the first paper from my postdoc @VanAllenLab @DanaFarber: biorxiv.org/content/10.110… 1/12
account_circle
Eddy Saad(@eddy_saad) 's Twitter Profile Photo

Excited to share our work The Oncologist co-led by Georges Gebrael and mentored by Toni Choueiri, MD Daniel Heng

While smoking cessation is crucial 🚭, smoking status does not independently affect outcomes in pts w/ treated w/ 1L ICI

OncoAlert UroToday.com
tinyurl.com/mv44nycci

Excited to share our work @OncJournal co-led by @ggebraelmd and mentored by @DrChoueiri @DrDanielHeng While smoking cessation is crucial 🚭, smoking status does not independently affect outcomes in pts w/ #mRCC treated w/ 1L ICI @OncoAlert @urotoday tinyurl.com/mv44nycci
account_circle
Toni Choueiri, MD(@DrChoueiri) 's Twitter Profile Photo

1/ The long-awaited OS results from -564 are out NEJM! The 1st phase 3 trial to demonstrate a survival benefit for adjuvant treatment in .

nejm.org/doi/full/10.10…

1/ The long-awaited OS results from #KEYNOTE-564 are out @NEJM! The 1st phase 3 trial to demonstrate a survival benefit for adjuvant treatment in #RCC. nejm.org/doi/full/10.10…
account_circle
Fabrice Barlesi(@barlesi) 's Twitter Profile Photo

🇺🇸 Launch of the Third Transatlantic exchange in Oncology in Boston.

Dana-Farber and Gustave Roussy are proud to share their progress in treatment. 🤝

Liquid biopsy is an unprecedented advance that will change the way we treat patients with cancer.

🇺🇸 Launch of the Third Transatlantic exchange in Oncology in Boston. @DanaFarber and @GustaveRoussy are proud to share their progress in #cancer treatment. 🤝 Liquid biopsy is an unprecedented advance that will change the way we treat patients with cancer.
account_circle
Dana-Farber News(@DanaFarberNews) 's Twitter Profile Photo

Erica Pimenta, MD, PhD, Dana-Farber has received the QuadW Foundation Sarcoma Research Fellowship in Memory of Willie Tichenor for investigating IGF1 loss as a molecular driver of liposaracoma de-differentiation.

ms.spr.ly/6014cFTka

Erica Pimenta, MD, PhD, @DanaFarber has received the #AACR24 QuadW Foundation Sarcoma Research Fellowship in Memory of Willie Tichenor for investigating IGF1 loss as a molecular driver of liposaracoma de-differentiation. ms.spr.ly/6014cFTka
account_circle
Cancer Cell(@Cancer_Cell) 's Twitter Profile Photo

Online Now: Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes dlvr.it/T54zLq

Online Now: Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes dlvr.it/T54zLq
account_circle
Renee Maria Saliby(@ReneeSaliby) 's Twitter Profile Photo

Thank you Journal of Clinical Pathways for highlighting our study about intermediate endpoints in the era of ICI-based therapies in Toni Choueiri, MD Daniel Heng IMDC

➡️We look forward to further this research with collaborative efforts!

hmpgloballearningnetwork.com/site/jcp/video…

Dana-Farber Lank Center for Genitourinary Oncology

account_circle
Chris Labaki(@Chrislabaki1) 's Twitter Profile Photo

Congratulations to Roy Chebel on matching as PGY2 UW-Madison Department of Surgery !! A very well-deserved achievement.

One of the most dedicated and hardworking persons out there.
USJ

account_circle
BIDMC Department of Medicine(@BIDMC_Medicine) 's Twitter Profile Photo

Congratulations on  to our 70 newest Internal Medicine Residents! We're all so excited to welcome you to BIDMC IM Residency and BIDMC, and can't wait to work with you! 🌟🩺🎉

Congratulations on #MatchDay2024 to our 70 newest Internal Medicine Residents! We're all so excited to welcome you to @BIDMC_IM and @BIDMChealth, and can't wait to work with you! 🌟🩺🎉
account_circle